UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against AcelRx Pharmaceuticals, Inc. & Its Board o...
November 17 2014 - 6:48PM
Business Wire
Levi & Korsinsky announces that a class action lawsuit has
been commenced in the USDC for the Northern District of California
on behalf of investors who purchased or otherwise acquired AcelRx
Pharmaceuticals, Inc. (“AcelRx” or the “Company”) (Nasdaq:ACRX)
common stock and/or call options, or sold/wrote AcelRX’s put
options between December 2, 2013 and September 25, 2014.
For more information, click here:
http://zlk.9nl.com/acelrx-pharmaceuticals-acrx.
The Complaint alleges that defendants made false and/or
misleading statements and/or failed to disclose during the Class
Period: (1) that the Instructions for Use (IFU) for Zalviso were
not designed to adequately address the risk of the inadvertent
misplacement of tablets; and (2) that the Company had not submitted
to the FDA sufficient data to support the shelf life of the
product.
On July 25, 2014, AcelRx announced that it had received a
Complete Response Letter from the FDA regarding its New Drug
Application for Zalviso. Then on September 26, 2014, AcelRx
revealed that the resubmission process for its Zalviso NDA would
not be complete until the first quarter of 2015 at the earliest. On
this news, shares of AcelRx declined over 19%, to close on
September 26, 2014 at $5.41 per share, on unusually heavy
volume.
If you suffered a loss in AcelRx you have until December 1, 2014
to request that the Court appoint you as lead plaintiff. Your
ability to share in any recovery doesn’t require that you serve as
a lead plaintiff. To obtain additional information, contact Joseph
E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at
(212) 363-7500, toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/acelrx-pharmaceuticals-acrx.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s 28
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.30 Broad Street - 24th FloorNew York, NY 10004Tel: (212)
363-7500Toll Free: (877) 363-5972Fax: (866) 367-6510www.zlk.com
AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
From Sep 2024 to Oct 2024
AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
From Oct 2023 to Oct 2024